Acetylcholine Esterase Gene Expression in Salivary Glands of Albino Rats after Treatment with amitriptyline or/and Ashwagandha | ||||
| Journal of Applied Veterinary Sciences | ||||
| Article 11, Volume 8, Issue 1, January 2023, Page 72-77 PDF (779.95 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/javs.2022.173225.1191 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Ismael R. Idrees 1; Ghada A. Taqa  2; Saba Kh. A. Ibrahim 3
| ||||
| 1Ministry of Health, Ninevah Health Directorate, Mosul, Iraq | ||||
| 2Professor in veterinary pharmacology and toxicology, College of Dentistry , Mosul university , Iraq | ||||
| 3Dental Basic Sciences Department , College of Dentistry, University of Mosul, Iraq | ||||
| Abstract | ||||
| Acetylcholinesterase is required as an enzyme to counteract the effects of acetylcholine.The aim of the study is to assess how amitriptyline and Ashwagandha affect the acetylcholinesterase gene in rat salivary glands.Forty healthy albino rats were divided randomly into four equal groups: Group I (control) received distilled water for 30 days. Group II received amitriptyline (10mg/kg) for 30 days. Group III received ashwagandha watery root extract (200mg/kg) orally for 30 days and Group IV received the combination of amitriptyline orally and ashwagandha root extract orally for 30 days. Rats in each group were sacrificed after day 30 and salivary glands were dissected for measurement of the acetylcholinesterase gene using a Polymerase Chain Reaction technique (PCR). Acetylcholinesterase gene measurements reveal an increase in groups treated with amitriptyline alone (1.55±0.11) and in the group treated with a combination of amitriptyline with Ashwagandha (1.92±0.16), in comparison with the control group. There were no discernible differences between the Ashwagandha treated group (1.073± 0.25) compared to the control group (0.76±0.19).In conclusion, Amitriptyline alone and, when combined with Ashwagandha cause transcription of the acetylcholinesterase gene. | ||||
| Keywords | ||||
| Acetylcholinesterase gene; Amitriptyline; Ashwagandha; Salivary glands | ||||
| References | ||||
|
ALI, Z. and BHASKAR, S.B., 2016. Basic statistical tools in research and data analysis. Indian journal of anaesthesia, 60(9), p.662. https://doi.org/10.4103/0019-5049.190623
AL MAHMUD, Z., EMRAN, T. B., QAIS, N., BACHAR, S. C., SARKER, M., and UDDIN, M. M. N., 2016. Evaluation of analgesic, anti-inflammatory,thrombolytic and hepatoprotective activities of roots of Premna esculenta (Roxb). Journal of basic and clinical physiology and pharmacology, 27(1), 63-70.
BEHL, T., SHARMA, A., SHARMA, L., SEHGAL, A., ZENGIN, G., BRATA, R., and BUNGAU, S., 2020. Exploring the multifaceted therapeutic potential of withaferin A and its derivatives. Biomedicines, 8(12), 571. https://doi.org/10.3390/biomedicines8120571
BRONICK, L. M., and JASMIN, B. J., 2012. Trans-acting factors governing acetylcholinesterase mRNA metabolism in neurons. Front Mol Neurosci, 5, 36. https://doi.org/10.3389%2Ffnmol.2012.00036
CHEN, V. P., XE, H. Q., CHAN, W. K., LEUNG, K. W., CHOI, R. C. and TSIM , K. W., 2010. An induction effect of heat shock on the transcript of globular acetylcholinesterase in NG108-15 cells. Chemico-biological interactions, 187(1-3), 106-109. https://doi.org/10.1016/j.cbi.2010.02.024
DARREH- SHOR, T., ALMKVIST l, O., GUAN, Z. Z., GSRLIND, A., STRANDBERG, B., SVENSSON, A. L., and NORDBERG, A., 2002. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology, 59(4), 563-572. https://doi.org/10.1212/wnl.59.4.563.
GITENAY, D., and BARON, V. T., 2009. Is EGR1 a potential target for prostate cancer therapy? Future Oncol, 5, 993-1003. https://doi.org/10.2217/fon.09.67
GROS, M., GROSE, B., MESONERO, J. E., and LATERRE, E., 2021. Neurotransmitter dysfunction in irritable bowel syndrome: emerging approaches for management. Journal of Clinical Medicine, 10(15), 3429.https://doi.org/10.3390/jcm10153429.
GUNN, S. A., KREPS, L. M., ZHAO, H., LANDON, K., ILACQUA, J. S., and ADDISION, C. L., 2022. Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix. Journal of Bone Oncology, 100432. https://doi.org/10.1016/j.jbo.2022.100432
KIM, S., KIM, K., LEE, J. H., HAN, S. H., and LEE, S. H., 2019. Differential expression of acetylcholinesterase 1 in response to various stress factors in honey bee workers. Scientific reports, 9(1), 1-10. https://doi.org/10.1038/s41598-019-46842-0.
KONAR, A., GUPTA, R., SHUKLA, R. K., MALONEY, B., KHANNA, V. K., WADHWA, R., . and THAKUR, M. K., 2019. M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera. Scientific reports, 9(1), 1-15. https://doi.org/10.1038/s41598-019-48238-6.
LAYER, P. G., KLACZINSKI, J., SALFELDER, A., SPERLNG, L. E., THANGARAJ , G., TUSCHL, C., and VOGEL –HOPKER, A., 2013. Cholinesterases in development: AChE as a firewall to inhibit cell proliferation and support differentiation. Chemico-biological interactions, 203(1), 269-276. https://doi.org/10.1016/j.cbi.2012.09.014.
LI, Y., CAMP, S., RACHINSKY, T. L., BONGIORNO, C., and TAYLOR, P., 1993. Promoter elements and transcriptional control of the mouse acetylcholinesterase gene. J Biol Chem, 268, 3563-72. https://doi.org/10.1016/S0021-9258(18)53731-5.
LIN, X., and ZHANG, N., 2018. Berberine: Pathways to protect neurons. Phytotherapy Research, 32(8), 1501-1510.https://doi.org/10.1002/ptr.6107.
MAHMOUD, G. S., AHMED, A. H., and KASSIM, B. M., 2022. Assessment of histopathological and hematological changes in mice treated with the aqueous extract of origanum (Driganum majorana. L) in algabal Alakhder libya. Al-Salam Journal for Biochemical and Medical Science, 1(1), 12-17.
MASHIMO, M., MORIWAKI, Y., MISAWA, H., KAWASHIMA, K., and FUJI, T., 2021. Regulation of immune functions by non-neuronal acetylcholine (ACh) via muscarinic and nicotinic ACh receptors. International journal of molecular sciences, 22(13), 6818. https://doi.org/10.3390/ijms22136818.
MASSOULIE, J., BON, S., PERRIER, N., and FALASCA, C., 2005. The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring. Chem Biol Interact, 157-158, 3-14. https://doi.org/10.1016/j.cbi.2005.10.002.
MESHORER, E., and SORREG, H., 2006. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends in neurosciences, 29(4), 216-224. https://doi.org/10.1016/j.tins.2006.02.005
| ||||
|
Statistics Article View: 289 PDF Download: 308 |
||||
